Six-monthly De-worming in infants to study effects on growth by Awasthi, Shally & Pande, Vinod Kumar
Original Article
 Six−monthly De−worming in Infants to Study Effects on Growth
Shally Awasthi and Vinod Kumar Pande
Department of Pediatrics and Clinical Epidemiology Unit, King George's Medical College, Lucknow, India
Abstract. Objective : The study was conducted to assess the effectiveness of six monthly albendazole (ABZ) for improving the weight and height of preschool children when initia ted at
0.5−1 year of age in populations with a high transmission rate of intestinal roundworm, Ascaris lumbricoides. It was a cluster randomized trial in the urban slums of Lucknow, North
India. Methods : Control children received 2 ml (1 ml to infants) of Vitamin A every six month whereas those in the ABZ areas received, in addition, 400 mg of ABZ suspension (Zentel,
SKB) every six month. Sixty−three and sixty−one slum areas were randomized to albendazole (ABZ) or to control groups, respectively. Children aged 0.5−1 year were recruited in April
1996 and followed up for 1.5 years. Of 1022 children recruited from control and 988 from ABZ areas, the loss to follow−up at 1.5 year was 15.6% and 14.6% respectively. Mean (± SE)
weight gain in Kg in control versus ABZ areas was 3.04 (0.03) versus 3.22 (0.03), (p=0.01). Results : After controlling for the presence of weight−for age z−score <−2.00 at enrollment in
the ordinary least square's regression model, the extra weight gain in 1.5 years in those who received ABZ plus vitamin A was 0.13 Kg (95% CI: 0.004 to 0.26 Kg., p value=0.043) when
compared to those who received only vitamin A; underweight children at enrollment benefiting more than the normal ones. Conclusion : It was concluded that there was an improvement
in weight with six monthly ABZ over 1.5 years. However, a much larger trial would be needed to determine whether there is any net effect of improvement in weight on under five
mortality rate. [Indian J Pediatr 2001; 68 (9) : −827]
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It has been estimated that more than one third of the world population is infected with one
or several species of parasitic worms.1 One decade ago, it was estimated that in the Indian
subcontinent, there were 160 million cases of ascariasis and hookworm infestation each.1
The consequences of such infestations are malnutrition and anemia.1,2 Infestation in
children begins from the time weaning is started, around the age of six months, and by the
time they reach the school going age, helminths are the leading cause of disability3. Several
studies have also reported association between low vitamin A intake and impaired
growth4,5. Decreased absorption of vitamin A has been reported in enteric as well as other
infections6,7. A few randomized controlled trials have shown improvement in ponderal and
linear growth,8,9 but others have shown no association10. Concomitant administration of
vitamin A and deworming results in increased vitamin A absorption and serum retinol
levels11. Thus, vitamin A deficiency as well as worm infestation are both associated with
malnutrition. The critical period to tackle malnutrition, and thereby reduce malnutrition
related mortality, is in the preschool age group. Our study hypothesis was that albendazole
administration six monthly, as a single 400 mg dose in syrup, could be linked with the six
monthly vitamin A administration and may
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result in improvement in the nutritional status of the children. The objective was to study
the impact of four doses of albendazole and vitamin A administration between 6−12
months of age on weight gain after 1.5 years. Materials and Methods The study was
conducted in the slums where an anganwadi centers (AWC) was established under the
Integrated Child Development Services (ICDS) Scheme in urban Lucknow, North India.
The population of such slums is of about 1000, which includes about 100 children less than
5 years of age. The crude birth rate is 30.13 The family income is below the proverty line
and there are suboptimal living conditions. The AWC is a small room within the slum and
an anganwadi worker (AWW) is appointed for each AWC. The primary job responsibilities
of the AWW are to run a creche and provide primary health care and supplementary
nutrition for children less than six years of age and pregnant and lactating women. She also
maintains a survey register on the entire population with their ages.
This study was a randomized, community based trial. Cluster randomization was done to
have about 60 slums, with about 15 children, aged 0.5−1year, within each cluster, in each
arm. From 200 slums with a functional AWC in urban Lucknow, 124 were randomized to
receive either vitamin A (100,000 unitis) alone or albendazole (400 mg suspension) and
vitamin A (100,000 units) every six 
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mg suspension) and vitamin A (100,000 units) every six months for 1.5 years.
Included were children living in the slum area designated for the AWC and whose
age was between 0.5−1 years only, with written and informed consent of the
parents. The children were given vitamin A as well as albendazole from 6 months
of age.
The slums were visited by the project teams, eligible children identified and their
homes marked in a map of the slum prepared by the staff. The field staff had
master's degree in social work. They were supervised by a retired, registered nurse.
The supervisor validated 15% of the data collected by the field staff within one
week. The author (VKP) independently validated 5% of all the data collected within
3 days. Date of birth was abstracted from the register maintained by the AWW and
reconfirmed by asking the mother. At enrollment, in a few randomly selected slums
within the two groups, stool examination was done by direct fecal smear
examination.14 History of passage of roundworms in the preceding six months
before enrollment or between 2 consecutive visits was asked from the mother. The
weight and height were measured at enrollment and thereafter for every six months.
Each child was given the intervention after the measurements were taken. Death
was noted among the children.
The project team trained to measure weight and height and the inter−observer and
intra−observer coefficient of variation was of less than 5%. For those who could not
stand, lying down weight was measured on a Braun 
infant weighing spring scale with a precision of 50 GMs and length was measured
in a rigid infantometer with a precision of 1 mm. For those who could stand weight
was measured on a spring scales with a precision of 100 GMs and height was
measured in a stadiometer with a precision of 1 mn.
Analysis was done using EPI6 statistical software.15 Chi square test was used for
comparison of categorical variables and student's t test for continuous variables. A
two tailed chi square and t−test distribution was used and a p value of <0.05 was
considered to be statistically significant. An intention to treat analysis was done.
Ordinary least squares regression was done to find the association between weight
gain and height gain after controlling for initial weight or height for age and sex and
the treatment type given.15
ResultsThe study began in April 1996 and lasted for 1.5 years. There were 63 slums
with 988 children in the albendazole plus vitamin A group and 61 slums with 1022
children in the vitamin A group. The male to female ratio was 0.88 and 0.98 in the
albendazole plus vitamin A and vitamin A alone slums, respectively. The baseline
anthropometric characteristics are given in Table 1. The number of children
contacted at each follow−up visit is given in Table 2. At enrollment stool
examination was done in randomly selected 12 slums (n=196 children) which
received 
Table 1. Number of Subjects Enrolled and Contacted at Each Visit
Albendazole +Vitamin A Vitamin A P value
Number of Slums 63 61
Number of children 988 1022
Number of males 528 501 0.1
Number underweight 471 (47.2%) 480 (47.1%) 0.9
Number stunted 622 (66.3%) 609 (59.7%) 0.3
Number wasted 174 (17.6%) 166 (16.2%) 0.5
Mean, SE Mean, SE
Age (months) 9.4, 0.69 9.6 0.58
Weight (KG) 6.97, 0.14 7.03, 0.15 0.3
Height (CM) 64.9, 3.25 65.63, 3.17 0.4
WAZ −1.98, 0.13 −1.99, 0.13 0.8
HAZ −2.43, 0.21 −2.44, 0.2 0.9
WHZ −0.07, 0.25  −0.09, 0.24 0.8
Abbreviations:
WAZ: Weight−for−age z−score HAZ: Height−for−age z−score WHZ : Weight−for−height z−score
Table 2. Number of Children Enrolled and Contacted at Each Follow−up
Albendazole +Vitamin A Vitamin A P value
Enrolled 988 1022
After 6 months 941 968
After 12 months 832 831
After 18 months 832 840
Loss to follow−up* 13.9% 16.2% 0.6%
Dead over 1.5 years 21 20 0.7
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albendazole with vitamin A and in 11 slums (n=161 children) which received vitamin A
alone. The baseline prevalence of infestation with Ascaris lumbricoides was 8.16% in the
albendazole plus vitamin A slums and 9.32% in vitamin A slums (p value=0.2). At
enrollment, 8 and 10 mothers from the albendazole plus vitamin A group and vitamin A
group, respectively, gave history of passage of round−worms. At the second, third and
fourth visits after 6 months, 12 months and 18 months the percentages in the albendazole
plus vitamin A versus vitamin A groups were 2.7% (n=25) vs. 0.93% (n=9) (p=0.006),
2.31% (n=19) vs. 0.36% (n=3) (p=0.001) and 36.2% (n=301) vs. 17.0% (n=143)
(p=0.0001).
The mean weight gain in 1.5 years in the albendazole plus vitamin A group was 5.57%
greater than that in the vitamin A group alone (3.22 KG(SD: 2.03, SE: 0.26) vs. 3.05KG
(SD: 1.47 SE: 0.19)P value=0.01) (Table 3). The mean height gain in 1.5 years was similar
in both the groups (Table 3). Those who gave history of passage of round worms at the 18
month visit had a 13.1% greater weight gain in the albendazole plus vitamin A group as
compared to those in the vitamin A group and the difference was statistically significant
(p=0.007) (Table 3).
There was a statistically significant association between treatment type and weight gain
after controlling for presence of underweight at recruitment (Table 4).
Table 3. Anthropometric Characteristics of Children in Both the Group at 18 months
Albendazole +VitaminA Vitamin A P value
n Mean, SE n Mean, SE
Age after 18 month 832 27.5, 2.88 840 27.39, 2.78 0.5
Weight at 1.5 years (KG) 832 9.94, 0.02 840 9.87, 0.02 0.3
Height at 1.5 years (CM) 832 81.75, 0.5 840 81.60, 0.5 0.6
WAZ 832 −2.23, 0.94 840 −2.25, 0.91 0.6
HAZ 832 −1.89,1.49 840 −1.89, 1.45 0.9
WHZ 832 −1.28, 0.76 840 −1.31, 0.76 0.5
Number underweight 552 (66.3%) 580 (69.1%) 0.2
Number stunted 455 (54.7%) 441 (52.5%) 0.3
Number wasted 123 (14.8%) 133 (15.8%) 0.5
Weight gain (KG) at 1.5 years and stratified by sex and history of passage of round worms at the fourth follow−up and changes in weight for age−zscores
n Mean, SE n Mean, SE
Over−all 832 3.22, 0.26 840 3.05, 0.19 0.01
Stratified by sex 
In males 444 3.31, 0.18 405 3.14, 0.19 0.08
In females 388 3.11, 0.18 435 2.96, 0.31 0.1
(P value) (0.04) (0.08)
Stratified by history of passage of round worms at 4th follow−up
H/O roundworms 301 3.28, 0.17 143 2,90, 0.17 0.007
No (H/O) roundworms 531 3.18, 0.18 697 3.08, 0.18 0.2
(p value) (0.7) (0.2)
Change in weight−for−age
z−score 832 −0.22, 0.15 840 −0.25, 0.16 0.7
Height gain (CM) at 1.5 years stratified by sex and history of passage of round worms at the forth follow−up and changes in height for age−z−scores
n Mean, SE n Mean, SE
n Mean, SE n Mean, SE
Overall 832 16.5, 0.82 840 16.1, 0.83 0.2
Stratified by sex 
In males 444 16.72, 0.76 405 16.34, 0.83 0.7
In females 388 16.31, 0.76 435 15.94, 0.84 0.6
(p value)  (0.4) (0.4)
Stratified by history of passage of round wormd at 4th follow−up
H/O roundworms 301 16.10, 0.79 143 15.36, 0.78 0.1
No H/O roundworms 531 16.77, 0.83 697 16.29, 0.84 0.1
(p value) (0.4) (0.3)
Change in height−for−age
z−score 832 0.67, 0.26 840 0.48, 0.26 0.05
Abbreviations: WAZ: Weight−for−age z−score HAZ: Height−for−age z−score WHZ: Weight−for−height z−score
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Table 4. Ordinary Least Squares Regression for Association Between Weight Gain in Kg. over 1.5 Years and Underweight Status at Enrollment and Treatment Type
Coef. SE 95% CI P Coding 
Under weight 0.94 0.06 0.81 to 1.06 <0.0001 0=Normal,
(at enrollment) 1=Underweight
Treatment type 0.13 0.06 0.004 to 0.26 0.043 0=Vit A,
1=ABZ+Vit A
Constant 2.38 0.05 2.27 to 2.49 <0.0001
Number of observations = 1672
F (2, 1670) = 109.06
Prob> F = 0.0000
R−squared = 0.1155
Adjusted R−squared = 0.1145
 Abbreviations : Coef = Coefficient SE=Standard Error CI: Confidence Interval
ABZ=Albendazole Vit A: Vitamin A
Discussion
Since malnutrition and worm infestation both begin between the ages of 6 to 12 months,
this was taken as the age of recruitment. Recruited infants were contacted once every six
months and followed up for 1.5 years. This trial was conducted on children between the
ages of 6−12 months using cluster randomization. Asignificant improvement in weight was
observed in the children who were de−wormed every six months for 1.5 years at the end of
the study period. Intestinal helminths are know to cause malnutrition due to impaired
absorption of nutrients from the alimentary tract and improvements in weight have been
documented after deworming by various workers.1,16,17 However, most of the studies
have been done in school age children.18,20 There are a few studies in the preschool
children too showing similar effects.16,21,22 
The current trial has recruited the youngest subjects with reference to all other published
studies. Mothers of about one−fourth of the children between the age of 1.5−2 year gave
history of passage of roundworms. This is indicative of high transmission rates within the
community. High transmission rates are found in areas where there is improper handling of
human excreta, which is the case in most of the urban slums of Lucknow. There was a
significantly greater weight gain but no height gain in the de−wormed children in 1.5 years
as compared to those who were not. Similar findings have been reported in another study in
older children from the Lucknow slums.23
The recruited subjects included those with normal weight−for age as well as
underweight.15 In the ordinary least squares regression model it was noted that the mean
weight gain was greater by 0.98 Kg in the underweight as compared to normal weight
children. Controlling for this, treatment with albendazole plus vitamin A demonstrated an
additional increase in weight gain in all. Thus, while treatment with albendazole and
Vitamin A is of benefit to all, but is likely to be more so to the underweight.
Over a period of 18 months, there was a similar 
increase in the proportion of underweight children in both the arms. However, the
proportion of stunted and wasted children was reduced in both the arms. There was an
incremental reduction in the proportion stunted (4.9%) and wasted (2.4%) with albendazole
and vitamin A when compared to vitamin A alone. Similar findings have been reported in
another study in a different set of children from the urban slums of Lucknow.16 The
children in the earlier study received 600 mg of powdered albendazole or powdered
placebo and were 1.5−3.5 years of age at inclusion.24
The limitations of the study are that the worm burden and plasma retinol levels were not
estimated. Also the trial was not blinded and hence this may have biased the results if the
investigators knew the study hypothesis. Also concomitant co−intervention of deworming
medications in the vitamin A alone group may have resulted in making the differences in
weight and height gain with albendazole plus vitamin A less. History of passage of
roundworms was asked from the mothers, even though no clear association between this
and slide positivity has been established. It was found that at each visit a statistically
significantly higher proportion gave history of passage of roundworms in the albendazole
plus vitamin A group. This can be attributed to albendazole. This could also make blinding
very difficult, hence it was not done in the current trial. Estimation of the intensity of
infestation was not a part of this study and therefore the characteristics of infants who are
likely to be benifited by early routine deworming could not be determined. Also a longer
follow−up could have determined if the growth benefits exist into preschool age and
validated the findings of earlier study from the same area reporting this.23 Since there was
an improvement in weight gain over 18 months in children recruited in infancy, further
studies with longer follow−up are needed to see the effects in later ages as well in under
five mortality rates.
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